Showing results (671-680 of 2,316) with videos related to
Sort By:
Pageof 232
Annual Review of Immunology|June 8, 1999
Evolution of antigen binding receptorsG W Litman, M K Anderson, J P RastAmerican Journal of Clinical Pathology|April 1, 1975
Spontaneous platelet aggregation. Occurrence in an asymptomatic individualC G Kardinal, L T Wegener, L K AndersonPediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|December 4, 2018
Moving Toward Excellence in Pediatric Physical Therapy Education: A Scoping ReviewDeborah K Anderson, Jennifer A Furze, James G MooreThe American Journal of Pathology|November 1, 1988
The aortic intima in organ culture. Response to culture conditions and partial endothelial denudationR W Jackman, S K Anderson, J D SheridanKidney International|April 25, 2001
Cholesterol ester accumulation: an immediate consequence of acute in vivo ischemic renal injuryR A Zager, A Johnson, K Anderson, et al.Brain Pathology (Zurich, Switzerland)|October 1, 1995
Fetal neural grafts and repair of the injured spinal cordD K Anderson, D R Howland, P J ReierThe Behavioral and Brain Sciences|March 29, 2017
What BANE can offer GANE: Individual differences in function of hotspot mechanismsRebecca M Todd, Mana R Ehlers, Adam K AndersonArzneimittel-Forschung|January 1, 1980
Vinylogous carbinolamine tumor inhibitors. 7. Tumor inhibitory agents: bis-(N-alkylcarbamate) derivatives of 2,3-dihydro-5-(3',4'-dichlorophenyl)-6,7-bis(hydroxymethyl)-1H-pyrrolizineW K Anderson, J S New, P F CoreyJournal of Pharmaceutical Sciences|February 1, 1980
New compounds: synthesis of 2-chloromethylbenzo[b]furansW K Anderson, J C Bottaro, M J HalatJournal of Medicinal Chemistry|January 1, 1980
Synthesis and antileukemic activity of 1-methyl-2,5-diphenyl-3,4-bis(hydroxymethyl)-, 1,2,3-triphenyl-4,5-bis(hydroxymethyl)-, and 1-methyl-2,3-diphenyl-4,5-bis(hydroxymethyl)pyrrole bis(N-methylcarbamate)W K Anderson, M J Halat, A C RickPageof 232